Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 406 AL 420

New Age Therapy for Alzheimer's Disease by Neuronal Network Reconstruction

Tohda C.

Biol Pharm Bull. 2016;39(10):1569-1575. doi: 10.1248/bpb.b16-00438.

Dazed and Confused: Medical Cannabis in Alzheimer Disease

Antonsdottir IM, Makino KM, Porsteinsson AP.

Am J Geriatr Psychiatry. 2016 Nov;24(11):1004-1006. doi: 10.1016/j.jagp.2016.08.015. Epub 2016 Aug 31.

Therapeutic strategies for the treatment of tauopathies: Hopes and challenges

Khanna MR, Kovalevich J, Lee VM, Trojanowski JQ, Brunden KR.

Alzheimers Dement. 2016 Oct;12(10):1051-1065. doi: 10.1016/j.jalz.2016.06.006.

Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links

Ribe EM, Lovestone S.

J Intern Med. 2016 Nov;280(5):430-442. doi: 10.1111/joim.12534. Epub 2016 Oct 14.

A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice

Maiti P, Hall TC, Paladugu L, Kolli N, Learman C, Rossignol J, Dunbar GL.

Histochem Cell Biol. 2016 Nov;146(5):609-625. doi: 10.1007/s00418-016-1464-1. Epub 2016 Jul 12.

Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy

Liu J, Yang B, Ke J, Li W, Suen WC.

Drugs Aging. 2016 Oct;33(10):685-697. doi: 10.1007/s40266-016-0406-x.

When, where and how? Focus on neuronal calcium dysfunctions in Alzheimer's Disease

Agostini M, Fasolato C.

Cell Calcium. 2016 Nov;60(5):289-298. doi: 10.1016/j.ceca.2016.06.008. Epub 2016 Jul 9.

MEF2C rs190982 polymorphism with late-onset Alzheimer's disease in Han Chinese: A replication study and meta-analyses

Tang SS, Wang HF, Zhang W, Kong LL, Zheng ZJ, Tan MS, Tan CC, Wang ZX, Tan L, Jiang T, Yu JT, Tan L.

Oncotarget. 2016 Jun 28;7(26):39136-39142. doi: 10.18632/oncotarget.9819.

Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer's Disease

Ben Aissa M, Lee SH, Bennett BM, Thatcher GR.

Curr Med Chem. 2016;23(24):2770-2788. doi: 10.2174/0929867323666160812145454.

The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease

Grimm MO, Mett J, Hartmann T.

Int J Mol Sci. 2016 Oct 26;17(11):1785. doi: 10.3390/ijms17111785.

'From past to future' - deciphering the molecular basis of Alzheimer's disease through the pages of the Journal of Neurochemistry

Cappai R.

J Neurochem. 2016 Oct;139 Suppl 2:215-223. doi: 10.1111/jnc.13546. Epub 2016 Mar 21.

The amyloid cascade hypothesis: are we poised for success or failure?

Karran E, De Strooper B.

J Neurochem. 2016 Oct;139 Suppl 2:237-252. doi: 10.1111/jnc.13632. Epub 2016 Jun 3.

VITAMIN D IN ALZHEIMER'S DISEASE - PROPHYLAXIS OR THERAPY?

Gruber-Bzura BM.

Acta Pol Pharm. 2016 Nov;73(6):1427-1431.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias